<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Medicine / Prescription Drug User Fee Act / Orphan drug / Generic drug / Investigational New Drug / Pharmaceuticals policy / Food and Drug Administration / Health
Pharmaceutical sciences
Medicine
Prescription Drug User Fee Act
Orphan drug
Generic drug
Investigational New Drug
Pharmaceuticals policy
Food and Drug Administration
Health

Small Business Assistance: Financial Assistance and Incentives for Research and Development of New Drug/Biologic Products

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 623,69 KB

Share Document on Facebook

Similar Documents

Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace

Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace

DocID: 1uvYN - View Document

Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic,

Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic,

DocID: 1sDEk - View Document

Emergency Use: means the use of a test article on a human subject in a life-threatening situation in

Emergency Use: means the use of a test article on a human subject in a life-threatening situation in

DocID: 1riMu - View Document

Microsoft Word - 7494fnl.doc

Microsoft Word - 7494fnl.doc

DocID: 1qYy2 - View Document

Microsoft Worddoc

Microsoft Worddoc

DocID: 1qVAJ - View Document